Agennix AG to Present at Lazard Capital Markets 6th Annual Healthcare
Conference
(Thomson Reuters ONE) - Corporate news announcement processed and transmitted by Hugin AS.The issuer is solely responsible for the content of this announcement. ------------------------------------------------------------------------------------ Martinsried/Munich (Germany), Princeton, N.J. and Houston, TX,November 13, 2009 - Agennix AG (Frankfurt Stock Exchange: AGX) todayannounced that the Company will give a corporate presentation at theupcoming Lazard Capital Markets 6th Annual Healthcare Conference. Thepresentation will be on Wednesday, November 18, at 2:15 p.m. ET atthe St Regis Hotel in New York City.The presentation will be webcast live and will be accessible throughthe Agennix Web site at www.agennix.com. A replay will also beavailable via the Web site.About AgennixAgennix AG is a publicly traded biopharmaceutical company focused ondeveloping novel anti-cancer therapies. The Company was formed by thecombination of GPC Biotech AG and Agennix Incorporated. The Company'smost advanced program is talactoferrin, an oral targeted therapy thatis in Phase 3 clinical trials in non-small cell lung cancer. Otherclinical development programs include RGB-286638, a multi-targetedkinase inhibitor in Phase 1 testing; the oral platinum-based compoundsatraplatin; and a topical gel form of talactoferrin for woundhealing. Agennix is a transatlantic company with sites in Munich,Germany; Princeton, New Jersey and Houston, Texas. For additionalinformation, please visit the Agennix Web site at www.agennix.com.This press release contains forward-looking statements, which expressthe current beliefs and expectations of the management of Agennix AG.Such statements are based on current expectations and are subject torisks and uncertainties, many of which are beyond our control, thatcould cause future results, performance or achievements to differsignificantly from the results, performance or achievements expressedor implied by such forward-looking statements. Actual results coulddiffer materially depending on a number of factors, and we cautioninvestors not to place undue reliance on the forward-lookingstatements contained in this press release. Forward-lookingstatements speak only as of the date on which they are made andAgennix undertakes no obligation to update these forward-lookingstatements, even if new information becomes available in the future.For further information, please contact:Agennix AGInvestor Relations & Corporate CommunicationsPhone: +49 (0)89 8565 2693ir(at)agennix.comIn the U.S.: Laurie DoyleDirector, Investor Relations & Corporate CommunicationsPhone: +1 609 524 5884laurie.doyle(at)agennix.comAdditional media contacts for Europe:MC Services AGPhone: +49 (0) 89 210 228 0Raimund Gabrielraimund.gabriel(at)mc-services.euHilda Juhaszhilda.juhasz(at)mc-services.euAdditional investor contact for Europe:Trout International LLCLauren (Rigg) Williams, Vice PresidentPhone: +44 207 936 9325lrigg(at)troutgroup.com --- End of Message ---Agennix AGFraunhoferstr. 20 Martinsried GermanyISIN: DE000A1A6XX4; Listed: Regulierter Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse;
Datum: 13.11.2009 - 11:02 Uhr
Sprache: Deutsch
News-ID 8366
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 251 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Agennix AG to Present at Lazard Capital Markets 6th Annual Healthcare
Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Agennix AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
